Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Code Eclampsia: Navigating the Storm in ED Management

By Pauline Wiltz, DO | on August 25, 2025 | 2 Comments
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
  • fosphenytoin 20 mg PE/kg IV at 150 mg PE/min

If persistent:

You Might Also Like
  • Focus On Preeclampsia
  • Stroke in Pregnancy
  • How to Diagnose and Manage Hypertensive Disorders in Pregnancy
Explore This Issue
ACEP Now: August 2025 (Digital)
  • levetiracetam 60 mg/kg IV, maximum 4,500 mg
  • Consider intubation with propofol, consider consulting with neurology and plan for ICU admission

Resolution of Seizure6

Once seizure has been aborted, consider the following steps in ongoing resuscitation

  1. Assess BP: if systolic blood pressure >160 or diastolic blood pressure >110, initiate the Acute Hypertension Algorithm
  2. OB evaluation ASAP
  3. If seizure responds to magnesium and urgent transport to an obstetric unit for further evaluation is unavailable:
    1. Continue magnesium sulfate infusion 1-2 g/hr.
    2. Monitor magnesium levels every four hours (therapeutic range 4.9-8.5 mg/dL).
    3. Observe for magnesium toxicity.
  4. Maintain infusion for at least 24-48 hours after last seizure or delivery, whichever occurred latest.
  5. Obtain head computed tomography scan to rule out intracranial hemorrhage versus ischemia.
  6. Perform a thorough neurological exam.
  7. Preparation for delivery as applicable based on emergency department resources (i.e., admission to Labor and Delivery, transfer to facility with Labor and Delivery).

Magnesium Toxicity7

  • If serum magnesium >9.6 mg/dL, the infusion should be stopped and can be restarted once the level decreases to <8.4 mg/dL.
  • If a patient is demonstrating signs of respiratory depression secondary to magnesium toxicity, calcium gluconate or calcium chloride should be used as calcium directly antagonizes neuromuscular and cardiovascular effects of magnesium.
    • 10 percent calcium gluconate: 2-3 grams IV over three minutes
    • Ensure IV hydration to maintain magnesium excretion.
  • Effects of magnesium toxicity compound as the serum magnesium levels (mg/dL) increase. For reference:
    • 4.9-8.5: therapeutic range
    • 8.5-12: loss of deep tendon reflexes
    • 12-15: respiratory depression
    • >18: effects of cardiac conduction
    • >30: cardiac arrest

Conclusion

Eclampsia is a severe complication of pregnancy that poses significant risks to both the mother and the fetus. It is associated with maternal and fetal morbidity and mortality if not managed properly. Early identification of preeclampsia and timely medical intervention, such as the administration of magnesium sulfate to prevent seizures and the delivery of the baby, are crucial in mitigating the dangers of eclampsia. With appropriate care and management, many patients can go on to have healthy pregnancies, but awareness and vigilance remain essential for safeguarding the health of both parent and child.


Dr. Wiltz is a PGY-3 in emergency medicine and chief resident at Case Western Reserve University/University Hospitals in Cleveland, Ohio. She is also president-elect of the Emergency Medicine Residents’ Association.

 

References

  1. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-e260.
  2. Aukes AM, Yurtsever FN, Boutin A, et al. Associations between migraine and adverse pregnancy outcomes: systematic review and meta-analysis. Obstet Gynecol Surv. 2019;74(12):738-748.
  3. ACOG. Identifying and Managing Obstetric Emergencies in Nonobstetric Settings. https://www.acog.org/programs/obstetric-emergencies-in-nonobstetric-settings. Published 2024. Accessed April 1, 2025.
  4. ACOG. Acute Hypertension in Pregnancy and Postpartum Algorithm. https://www.acog.org/-/media/secure/programs/acog_urgent-care-acute-hypertension-in-pregnancy-and-postpartum-algorithm.pdf. Accessed July 9, 2025.
  5. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol. 2004;190(6):1520-1526.
  6. Schoen JC, Campbell RL, Sadosty AT. Headache in pregnancy: an approach to emergency department evaluation and management. West J Emerg Med. 2015;16(2):291-301.
  7. Kerrigan K, Smith L. Preeclampsia/Eclampsia. In: Swadron S, Nordt S, Mattu A, and Johnson W, eds. CorePendium. 5th ed. Burbank, CA: CorePendium, LLC. https://www.emrap.org/corependium/chapter/rec09jiLmoJ1dIM0l/PreeclampsiaEclampsia#h.y2w33fax0jwc. Updated February 7, 2025. Accessed April 4, 2025.

[This article was corrected on October 16, 2025, to state the appropriate laboratory levels for magnesium toxicity.]

Pages: 1 2 3 4 | Single Page

Topics: eclampsiaHypertensionmagnesium toxicityOB/GYNObstetricspreeclampsiaPregnancySeizure

Related

  • November 2025 News from the College

    November 4, 2025 - 0 Comment
  • Case Report: Massive Amitriptyline and Bupropion Ingestion

    October 29, 2025 - 0 Comment
  • August 2025 News from the College

    August 4, 2025 - 1 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

2 Responses to “Code Eclampsia: Navigating the Storm in ED Management”

  1. August 31, 2025

    Joshua Mastenbrook Reply

    Thank you for the great summary! At the end of the article in the paragraph listing magnesium levels and their expected effects, should the first range be “5-8.9” and the second be “9-12” instead of 9-8.9 and 5-12?

  2. September 22, 2025

    Yeop Kim Reply

    Can the author please reply/confirm Joshua Mastenbrook’s comment from August 31, 2025? Thanks!

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603